22732 Impact of Type-I Interferon Manipulation During Embryo Implantation and Placentation

ABSTRACT IMPACT: This research will promote understanding the role of the Type-I Interferon signaling pathway during embryo implantation, potentially leading to a new diagnostic or treatment target in early pregnancy failure. OBJECTIVES/GOALS: Studies suggest interferon signaling regulation is tight...

Full description

Bibliographic Details
Main Authors: Michael K. Simoni, Sydnie Swanson, Monica Mainigi, Kellie Jurado
Format: Article
Language:English
Published: Cambridge University Press 2021-03-01
Series:Journal of Clinical and Translational Science
Online Access:https://www.cambridge.org/core/product/identifier/S2059866121006440/type/journal_article
_version_ 1811155361194835968
author Michael K. Simoni
Sydnie Swanson
Monica Mainigi
Kellie Jurado
author_facet Michael K. Simoni
Sydnie Swanson
Monica Mainigi
Kellie Jurado
author_sort Michael K. Simoni
collection DOAJ
description ABSTRACT IMPACT: This research will promote understanding the role of the Type-I Interferon signaling pathway during embryo implantation, potentially leading to a new diagnostic or treatment target in early pregnancy failure. OBJECTIVES/GOALS: Studies suggest interferon signaling regulation is tightly balanced between physiologic and pathophysiologic growth in early pregnancy. We propose to determine the impact of interferon-mediated inflammation on embryo implantation and early pregnancy failure in normal conditions and chronic inflammatory diseases in a novel mixed-mouse model. METHODS/STUDY POPULATION: To probe the role of type-I interferons (IFNs) in implantation, we will utilize a mouse model and non-surgically transfer both Ifnar1-/- and Ifnar1-/+ embryos into an immune-competent pseudopregnant wild-type female recipient. This will allow analysis of a litter with distinct genotypes within the same, immune-competent, uterine environment. Type-I IFN stimulation will be systemically induced with Poly-(I:C) at various time points around implantation. A similar approach will be used in mouse models of chronic inflammatory disease states associated with early pregnancy loss (e.g. systemic lupous erythematous). With this model, we will be able to control for deficiencies in maternal immune response to specifically determine the embryonic response to inflammation during implantation and development. RESULTS/ANTICIPATED RESULTS: We anticipate the Ifnar1-/+ embryos - those able to respond to Type-I IFN - and their surrounding implantation sites will exhibit more maternal-fetal barrier dysfunction in the form of impaired trophoblast fusion, improper formation of the microvascular architecture, and increased permeability of the maternal-fetal barrier, compared to embryos unable to respond to IFN. We will also conduct similar analyses in mouse models of chronic inflammatory diseases. We hypothesize these mice to have baseline endometrial inflammation that stimulated the IFN-pathway in IFN-capable embryos, producing breakdown of the maternal-fetal barrier. In these mice, we predict Ifnar1-/- embryos will show improved molecular outcomes when compared to Ifnar1-/+ embryos, and thus improved associated pregnancy outcomes. DISCUSSION/SIGNIFICANCE OF FINDINGS: This work can insight into the immunological mechanisms that govern embryo implantation and early placentation. This could provide more pointed means for management and intervention of early pregnancy failure and/or disease states that are commonly associated with poor reproductive outcomes.
first_indexed 2024-04-10T04:32:51Z
format Article
id doaj.art-5f2d5a80dc19475e9d9e142a73dd254c
institution Directory Open Access Journal
issn 2059-8661
language English
last_indexed 2024-04-10T04:32:51Z
publishDate 2021-03-01
publisher Cambridge University Press
record_format Article
series Journal of Clinical and Translational Science
spelling doaj.art-5f2d5a80dc19475e9d9e142a73dd254c2023-03-10T07:52:02ZengCambridge University PressJournal of Clinical and Translational Science2059-86612021-03-015949510.1017/cts.2021.64422732 Impact of Type-I Interferon Manipulation During Embryo Implantation and PlacentationMichael K. Simoni0Sydnie Swanson1Monica Mainigi2Kellie Jurado3University of PennsylvaniaUniversity of PennsylvaniaUniversity of PennsylvaniaUniversity of PennsylvaniaABSTRACT IMPACT: This research will promote understanding the role of the Type-I Interferon signaling pathway during embryo implantation, potentially leading to a new diagnostic or treatment target in early pregnancy failure. OBJECTIVES/GOALS: Studies suggest interferon signaling regulation is tightly balanced between physiologic and pathophysiologic growth in early pregnancy. We propose to determine the impact of interferon-mediated inflammation on embryo implantation and early pregnancy failure in normal conditions and chronic inflammatory diseases in a novel mixed-mouse model. METHODS/STUDY POPULATION: To probe the role of type-I interferons (IFNs) in implantation, we will utilize a mouse model and non-surgically transfer both Ifnar1-/- and Ifnar1-/+ embryos into an immune-competent pseudopregnant wild-type female recipient. This will allow analysis of a litter with distinct genotypes within the same, immune-competent, uterine environment. Type-I IFN stimulation will be systemically induced with Poly-(I:C) at various time points around implantation. A similar approach will be used in mouse models of chronic inflammatory disease states associated with early pregnancy loss (e.g. systemic lupous erythematous). With this model, we will be able to control for deficiencies in maternal immune response to specifically determine the embryonic response to inflammation during implantation and development. RESULTS/ANTICIPATED RESULTS: We anticipate the Ifnar1-/+ embryos - those able to respond to Type-I IFN - and their surrounding implantation sites will exhibit more maternal-fetal barrier dysfunction in the form of impaired trophoblast fusion, improper formation of the microvascular architecture, and increased permeability of the maternal-fetal barrier, compared to embryos unable to respond to IFN. We will also conduct similar analyses in mouse models of chronic inflammatory diseases. We hypothesize these mice to have baseline endometrial inflammation that stimulated the IFN-pathway in IFN-capable embryos, producing breakdown of the maternal-fetal barrier. In these mice, we predict Ifnar1-/- embryos will show improved molecular outcomes when compared to Ifnar1-/+ embryos, and thus improved associated pregnancy outcomes. DISCUSSION/SIGNIFICANCE OF FINDINGS: This work can insight into the immunological mechanisms that govern embryo implantation and early placentation. This could provide more pointed means for management and intervention of early pregnancy failure and/or disease states that are commonly associated with poor reproductive outcomes.https://www.cambridge.org/core/product/identifier/S2059866121006440/type/journal_article
spellingShingle Michael K. Simoni
Sydnie Swanson
Monica Mainigi
Kellie Jurado
22732 Impact of Type-I Interferon Manipulation During Embryo Implantation and Placentation
Journal of Clinical and Translational Science
title 22732 Impact of Type-I Interferon Manipulation During Embryo Implantation and Placentation
title_full 22732 Impact of Type-I Interferon Manipulation During Embryo Implantation and Placentation
title_fullStr 22732 Impact of Type-I Interferon Manipulation During Embryo Implantation and Placentation
title_full_unstemmed 22732 Impact of Type-I Interferon Manipulation During Embryo Implantation and Placentation
title_short 22732 Impact of Type-I Interferon Manipulation During Embryo Implantation and Placentation
title_sort 22732 impact of type i interferon manipulation during embryo implantation and placentation
url https://www.cambridge.org/core/product/identifier/S2059866121006440/type/journal_article
work_keys_str_mv AT michaelksimoni 22732impactoftypeiinterferonmanipulationduringembryoimplantationandplacentation
AT sydnieswanson 22732impactoftypeiinterferonmanipulationduringembryoimplantationandplacentation
AT monicamainigi 22732impactoftypeiinterferonmanipulationduringembryoimplantationandplacentation
AT kelliejurado 22732impactoftypeiinterferonmanipulationduringembryoimplantationandplacentation